In vivo effect of α1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin

Archives Internationales de Pharmacodynamie et de Therapie

Volumn 331, Issue 3, 1996, Pages 313-321

  Muchitsch, E M ^a   Teschner, W ^a   Linnau, Y ^a   Pichler, L ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; EVANS BLUE; HISTAMINE; OROSOMUCOID; PLASMINOGEN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; ZK 42251;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; SKIN BLOOD FLOW;

ANIMALS; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; EVANS BLUE; GUINEA PIGS; HISTAMINE; MALE; OROSOMUCOID; PLASMINOGEN; SKIN;

EID: 0030444787     PISSN: 00039780     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. AGOSTINI, A., VERGANI, C., STABILINI, R., MARASINI, B., ARCIDIACONO, R., SBAFFI, A. and BINAGHI, P. C. Immunochemical quantitation of acute phase reactive proteins in myocardial infarction. Amer. Heart J. 80, 313-318 (1970).
2. ARUNLAKSHANA, O. and SCHILD, H. O. Some quantitative uses of drug antagonists. Brit. J. Pharmacol. 14, 48-58 (1959).
3. BESSIN, P., BONNET, J., APFFEL, D., SOULARD, C., DESGROUX, L., PELAS, I. and BENVENISTE, J. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Europ. J. Pharmacol. 86, 403-413 (1983).
4. CURRY, F. E., RUTLEDGE, J. C. and LENZ, J. F. Modulation of microvessel wall charge by plasma glycoprotein orosomucoid. Amer. J. Physiol. 257, H1354-H1359 (1989).
5. GLAUSER, M. P., ZANETTI, G., BAUMGARTNER, J.-D. and COHEN, J. Septic shock: Pathogenesis. Lancet 338, 732-736 (1991).
6. HARALDSSON, B. and RIPPE, B. Orosomucoid as one of the serum components contributing to normal capillary permselectivity in rat skeletal muscle. Acta physiol. scand. 129, 127-135 (1987).
7. HARALDSSON, B. S., JOHNSSON, E. K. A. and RIPPE, B. Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid. Kidney Int. 41, 310-316 (1992).
8. 1-acid glycoprotein against tumor necrosis factor-induced lethality. J. exp. Med. 180, 1571-1575 (1994).
9. MALIK, A. B., LO, S. K. and BIZIOS, R. Thrombin-induced alterations in endothelial permeability. Ann. N. Y. Acad. Sci. 485, 293-309 (1986).
10. 1-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions, and Pharmacology. Progr. Clin. Biol. Res., Vol. 300, pp. 307-319. Alan R. Liss, Inc., New York (1989).
11. PARKER, M. M. and PARRILLO, J. E. Septic shock. Hemodynamics and pathogenesis. J. amer. med. Ass. 250, 3324-3327 (1983).
12. SANN, L., BIENVENU, F., BIENVENU, J., BOURGEOIS, J. and BETHENOD, M. Evolution of serum prealbumin, C-reactive protein, and orosomucoid in neonates with bacterial infection. J. Pediat. 105, 977-981 (1984).
13. 1-Acid glycoprotein. In: Putnam, F. W. (Ed). The Plasma Proteins. Structure, Function and Genetic Control, Vol. 1, pp. 183-228. Academic Press, New York, 2nd Ed. (1975).
14. SCHNITZER, J. E. and PINNEY, E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: Role in capillary permeability. Amer. J. Physiol. 263, H48-H55 (1992).
15. VINAZZER, H. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Sem. Thromb. Hemost. 15, 347-352 (1989).